Palantir picked more than 20 SPACs to invest in and failed miserably. Almost a third of these companies are bankrupt, and the portfolio is down 87%. While PLTR has now exited this mess, one wonders why they couldn't have done a better job picking partners that could actually thrive. Then again, the entire universe of 110 SPACs we covered since they debuted shows similar pathetic performance. Retail investors were screwed over royally with more than 80% of these SPACs losing 50% or more of their value. While bag holders lick their wounds, investors on the sidelines who heeded our warnings may be looking for some value to be had in the remaining names. Indeed, there are some companies worth taking a closer look, and you'll just have to watch the video to see which ones they are. And if you're one of the ontology people who constantly sings the praises of Palantir and you're upset we said something bad about your sacred cow, here's what you do. Write down your complaint on a piece of paper, then crumple it up, throw it into the circular filing cabinet, and take the list of bullish bullet points you're getting ready to post somewhere else. We know Palantir cures cancer. We get that. We're here to talk about SPACs. Thanks in advance for your understanding.


Stay informed with our free disruptive technology investing newsletter, Nanalyze Weekly. Sign up now at ⁠https://www.nanalyze.com/nanalyze-weekly/⁠. This episode is pulled from a YouTube presentation. View the original presentation at ⁠https://youtu.be/2fT8ojoZmVc.

Ver todos los episodios